Examnitaion of the primary prevention effect of BPSD in the additional dosage of the mementine hydrochloride for the Alzheimer's disease
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000012340
- Lead Sponsor
- Osaka City University Graduate school of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1.dementia patients except Alzheimer's desease 2.the patients who have severe mental desorder 3.the patients having the serious disease including the malignant neoplasm 4.the patients with a history of the hypersensitivity for memantine hydrochloride 5.the patients who corresponds to a contraindication in an attached document 6.In addition, the case that a principal investigator or subinvestigator judged to be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BPSD
- Secondary Outcome Measures
Name Time Method Cognitive function Safety